Bloomberg Markets AI Drug Firm Insilico Debuts in Hong Kong After $293 Million IPO
AI-biotechnology firm Insilico Medicine Cayman TopCo is set to debut in Hong Kong on Tuesday after raising $293 million in its initial public offering.
AI-biotechnology firm Insilico Medicine Cayman TopCo is set to debut in Hong Kong on Tuesday after raising $293 million in its initial public offering.